The early molecular profile of glioma describing aberrant Epithelial Growth Factor Receptor (EGFR) transcripts [3] and mutations on the Tumor protein 53 (TP53) tumor suppressor gene [4] established new approaches to cancer characterization, other than histology and immunohistochemistry [5]. This evidence concerns the gene TP53 and glioma.